CYP3A4 and intracranial hemorrhage: Use of clopidogrel in patients with contraindication to ticagrelor (e.g. history of intracranial hemorrhage, moderate‐to‐severe hepatic impairment, concomitant use of strong CYP3A4 inhibitors) is reasonable.